Drugmaker Gilead Sciences Inc.

AIDS patients in poor areas to get medication access HIV/AIDS patients in poor countries may finally access the antiretroviral medications they desperately need sildenafil citrate 100mg . Drugmaker Gilead Sciences Inc. Tuesday its plan to allow four of its AIDS drugs to be made by generic producers announced, raising their availability in poor countries – especially in Africa potentially. The majority of the 33 million people worldwide who’ve HIV go on the continent. In the first offer of its kind, the pharmaceutical business agreed to provide the medicines in return for three to five % of royalties, US health officials said.

He tried to run his practice in your free time, using his personal savings to keep the clinic open up.’ In New York, he is working with experts examining a virus that is possibly associated with chronic exhaustion syndrome and autism . This article is republished with kind authorization from our friends at The Kaiser Family members Foundation. You will see the entire Kaiser Daily Health Policy Record, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Daily Health Plan Report is published for Kaisernetwork.org, a free support of The Henry J.